Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile

ABSTRACT: The incidence of opportunistic fungal infections has increased in recent decades due to the growing proportion of immunocompromised patients in our society. Candida krusei has been described as a causative agent of disseminated fungal infections in susceptible patients. Although its preval...

Full description

Autores:

Mesa Arango, Ana Cecilia
de Lucas, María Pilar
Scorzoni, Liliana
Fusco Almeida, Ana Marisa
Lozano, Encarnación
Cuenca Estrella, Manuel
Mendes Giannini, María José
Zaragoza, Oscar

Tipo de recurso:

Article of investigation

Fecha de publicación:

2013

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/39059

Acceso en línea:

https://hdl.handle.net/10495/39059

Palabra clave:

Anfotericina B - uso terapéutico
Amphotericin B - therapeutic use
Antifúngicos - uso terapéutico
Antifungal Agents - therapeutic use
Caenorhabditis elegans
Candida
Candidiasis
Fluconazol
Fluconazole
Lepidópteros
Lepidoptera
Pirimidinas
Pyrimidines
Triazoles
Voriconazol
Voriconazole
https://id.nlm.nih.gov/mesh/D000666
https://id.nlm.nih.gov/mesh/D000935
https://id.nlm.nih.gov/mesh/D017173
https://id.nlm.nih.gov/mesh/D002175
https://id.nlm.nih.gov/mesh/D002177
https://id.nlm.nih.gov/mesh/D015725
https://id.nlm.nih.gov/mesh/D007915
https://id.nlm.nih.gov/mesh/D011743
https://id.nlm.nih.gov/mesh/D014230
https://id.nlm.nih.gov/mesh/D065819

Rights

openAccess

License

https://creativecommons.org/licenses/by/4.0/